# Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome

> **NCT03818854** · PHASE2 · COMPLETED · sponsor: **Michael A. Matthay** · enrollment: 120 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Adult

## Interventions

- **BIOLOGICAL:** Human Mesenchymal Stromal Cells
- **BIOLOGICAL:** Cell Reconstitution Media

## Key facts

- **NCT ID:** NCT03818854
- **Lead sponsor:** Michael A. Matthay
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-26
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03818854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03818854, "Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03818854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*